Mechanism-based traps enable protease and hydrolase substrate discovery

Hydrolase enzymes, including proteases, are encoded by 2–3% of the genes in the human genome and 14% of these enzymes are active drug targets1. However, the activities and substrate specificities of many proteases—especially those embedded in membranes—and other hydrolases remain unknown. Here we re...

Full description

Bibliographic Details
Main Authors: Tang, S, Beattie, AT, Kafkova, L, Petris, G, Huguenin-Dezot, N, Fiedler, M, Freeman, M, Chin, JW
Format: Journal article
Language:English
Published: Springer Nature 2022
_version_ 1797106773201518592
author Tang, S
Beattie, AT
Kafkova, L
Petris, G
Huguenin-Dezot, N
Fiedler, M
Freeman, M
Chin, JW
author_facet Tang, S
Beattie, AT
Kafkova, L
Petris, G
Huguenin-Dezot, N
Fiedler, M
Freeman, M
Chin, JW
author_sort Tang, S
collection OXFORD
description Hydrolase enzymes, including proteases, are encoded by 2–3% of the genes in the human genome and 14% of these enzymes are active drug targets1. However, the activities and substrate specificities of many proteases—especially those embedded in membranes—and other hydrolases remain unknown. Here we report a strategy for creating mechanism-based, light-activated protease and hydrolase substrate traps in complex mixtures and live mammalian cells. The traps capture substrates of hydrolases, which normally use a serine or cysteine nucleophile. Replacing the catalytic nucleophile with genetically encoded 2,3-diaminopropionic acid allows the first step reaction to form an acyl-enzyme intermediate in which a substrate fragment is covalently linked to the enzyme through a stable amide bond2; this enables stringent purification and identification of substrates. We identify new substrates for proteases, including an intramembrane mammalian rhomboid protease RHBDL4 (refs. 3,4). We demonstrate that RHBDL4 can shed luminal fragments of endoplasmic reticulum-resident type I transmembrane proteins to the extracellular space, as well as promoting non-canonical secretion of endogenous soluble endoplasmic reticulum-resident chaperones. We also discover that the putative serine hydrolase retinoblastoma binding protein 9 (ref. 5) is an aminopeptidase with a preference for removing aromatic amino acids in human cells. Our results exemplify a powerful paradigm for identifying the substrates and activities of hydrolase enzymes.
first_indexed 2024-03-07T07:07:15Z
format Journal article
id oxford-uuid:12d03675-5be3-46a8-8d9c-c5a367e1362d
institution University of Oxford
language English
last_indexed 2024-03-07T07:07:15Z
publishDate 2022
publisher Springer Nature
record_format dspace
spelling oxford-uuid:12d03675-5be3-46a8-8d9c-c5a367e1362d2022-05-18T09:50:53ZMechanism-based traps enable protease and hydrolase substrate discoveryJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:12d03675-5be3-46a8-8d9c-c5a367e1362dEnglishSymplectic ElementsSpringer Nature2022Tang, SBeattie, ATKafkova, LPetris, GHuguenin-Dezot, NFiedler, MFreeman, MChin, JWHydrolase enzymes, including proteases, are encoded by 2–3% of the genes in the human genome and 14% of these enzymes are active drug targets1. However, the activities and substrate specificities of many proteases—especially those embedded in membranes—and other hydrolases remain unknown. Here we report a strategy for creating mechanism-based, light-activated protease and hydrolase substrate traps in complex mixtures and live mammalian cells. The traps capture substrates of hydrolases, which normally use a serine or cysteine nucleophile. Replacing the catalytic nucleophile with genetically encoded 2,3-diaminopropionic acid allows the first step reaction to form an acyl-enzyme intermediate in which a substrate fragment is covalently linked to the enzyme through a stable amide bond2; this enables stringent purification and identification of substrates. We identify new substrates for proteases, including an intramembrane mammalian rhomboid protease RHBDL4 (refs. 3,4). We demonstrate that RHBDL4 can shed luminal fragments of endoplasmic reticulum-resident type I transmembrane proteins to the extracellular space, as well as promoting non-canonical secretion of endogenous soluble endoplasmic reticulum-resident chaperones. We also discover that the putative serine hydrolase retinoblastoma binding protein 9 (ref. 5) is an aminopeptidase with a preference for removing aromatic amino acids in human cells. Our results exemplify a powerful paradigm for identifying the substrates and activities of hydrolase enzymes.
spellingShingle Tang, S
Beattie, AT
Kafkova, L
Petris, G
Huguenin-Dezot, N
Fiedler, M
Freeman, M
Chin, JW
Mechanism-based traps enable protease and hydrolase substrate discovery
title Mechanism-based traps enable protease and hydrolase substrate discovery
title_full Mechanism-based traps enable protease and hydrolase substrate discovery
title_fullStr Mechanism-based traps enable protease and hydrolase substrate discovery
title_full_unstemmed Mechanism-based traps enable protease and hydrolase substrate discovery
title_short Mechanism-based traps enable protease and hydrolase substrate discovery
title_sort mechanism based traps enable protease and hydrolase substrate discovery
work_keys_str_mv AT tangs mechanismbasedtrapsenableproteaseandhydrolasesubstratediscovery
AT beattieat mechanismbasedtrapsenableproteaseandhydrolasesubstratediscovery
AT kafkoval mechanismbasedtrapsenableproteaseandhydrolasesubstratediscovery
AT petrisg mechanismbasedtrapsenableproteaseandhydrolasesubstratediscovery
AT huguenindezotn mechanismbasedtrapsenableproteaseandhydrolasesubstratediscovery
AT fiedlerm mechanismbasedtrapsenableproteaseandhydrolasesubstratediscovery
AT freemanm mechanismbasedtrapsenableproteaseandhydrolasesubstratediscovery
AT chinjw mechanismbasedtrapsenableproteaseandhydrolasesubstratediscovery